Characteristics (No. of patients) | PD1hi | PD1low | P-value |
---|---|---|---|
Gender | |||
Male | 28 | 19 | |
Female | 18 | 16 | 0.552 |
Age(years) | |||
≥ 60 | 20 | 18 | |
< 60 | 26 | 17 | 0.478 |
ECOG PS | |||
0 | 23 | 14 | |
1 | 23 | 21 | 0.371 |
Size of primary tumor (cm) | |||
≥ 5 | 4 | 3 | |
< 5 | 42 | 32 | 0.984 |
Histopathological grading | |||
Low | 20 | 17 | |
Intermediate to high | 26 | 18 | 0.649 |
TNM stage | |||
I + II | 24 | 30 | |
III | 22 | 5 | 0.002 |
Lymph node invasion | |||
Yes | 13 | 3 | |
No | 33 | 32 | 0.027 |
Microvascular invasion | |||
Yes | 11 | 6 | |
No | 35 | 29 | 0.459 |
HBV | |||
Yes | 18 | 2 | |
No | 28 | 33 | 0.001 |
HCV | |||
Yes | 1 | 1 | |
No | 45 | 34 | 0.844 |
Liver cirrhosis | |||
Yes | 6 | 4 | |
No | 40 | 31 | 0.827 |
Child–Pugh grade | |||
A | 6 | 8 | |
B | 40 | 27 | 0.247 |
CEA (ng/mL) | |||
≥ 10 | 5 | 2 | |
< 10 | 41 | 33 | 0.413 |
CA199(U/mL) | |||
≥ 60 | 32 | 30 | |
< 60 | 14 | 5 | 0.089 |
CA724(U/mL) | |||
≥ 14 | 34 | 21 | |
< 14 | 12 | 14 | 0.184 |
ALT(U/L) | |||
≥ 80 | 33 | 23 | |
< 80 | 13 | 12 | 0.561 |
AST(U/L) | |||
≥ 70 | 30 | 20 | |
< 70 | 16 | 15 | 0.459 |
Total bilirubin (umol/L) | |||
≥ 42 | 38 | 31 | |
< 42 | 8 | 4 | 0.454 |
Direct bilirubin (umol/L) | |||
≥ 16 | 42 | 30 | |
< 16 | 4 | 5 | 0.428 |
Indirect bilirubin (umol/L) | |||
≥ 30 | 30 | 19 | |
< 30 | 16 | 16 | 0.319 |